Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 4.42 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | 16.6 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | 6.32 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 6.96 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | 5.39 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 5.61 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 6.54 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 7.65 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 0.0 | BCD100322A001 | 2.12 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 0.5 | BCD100322A003 | 5.57 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 1.0 | BCD100322A007 | 8.61 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 2.0 | BCD100322A011 | 2.6 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 4.0 | BCD100322A015 | 3.29 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 8.0 | BCD100322A019 | 3.55 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 12.0 | BCD100322A023 | 3.15 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | C | 24.0 | BCD100322A027 | 5.08 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 12.2 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 6.82 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | 2.92 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | 8.38 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 4.73 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | 9.66 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 8.47 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 0.5 | BCD100322A004 | 6.82 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 1.0 | BCD100322A008 | 7.41 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 2.0 | BCD100322A012 | 2.39 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 4.0 | BCD100322A016 | 5.31 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 8.0 | BCD100322A020 | 5.8 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 12.0 | BCD100322A024 | 4.91 | pmol/ug DNA |
| LMFA01010014 | Myristic acid | 25OH-Chol | 24.0 | BCD100322A028 | 3.56 | pmol/ug DNA |